502 related articles for article (PubMed ID: 24597398)
1. Release of leukotriene B4, transforming growth factor-beta1 and microparticles in relation to aortic valve calcification.
Kochtebane N; Passefort S; Choqueux C; Ainoun F; Achour L; Michel JB; Bäck M; Jacob MP
J Heart Valve Dis; 2013 Nov; 22(6):782-8. PubMed ID: 24597398
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1-Induced MAPK activation promotes collagen synthesis, nodule formation, redox stress and cellular senescence in porcine aortic valve interstitial cells.
Das D; Holmes A; Murphy GA; Mishra K; Rosenkranz AC; Horowitz JD; Kennedy JA
J Heart Valve Dis; 2013 Sep; 22(5):621-30. PubMed ID: 24383372
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
5. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
6. miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis.
Yanagawa B; Lovren F; Pan Y; Garg V; Quan A; Tang G; Singh KK; Shukla PC; Kalra NP; Peterson MD; Verma S
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):256-62. PubMed ID: 22336757
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of cystatin C and transforming growth factor β-1 in calcific aortic valves.
Yetkin E; Tchaikovski V; Erdil N; Alan S; Waltenberger J
Int J Cardiol; 2014 Oct; 176(3):1252-4. PubMed ID: 25124995
[No Abstract] [Full Text] [Related]
8. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
9. [The calcified aortic valve. A morphologic study].
Brugger JM; Schneider J
Schweiz Med Wochenschr; 1986 Jan; 116(2):44-9. PubMed ID: 3945789
[TBL] [Abstract][Full Text] [Related]
10. Association between shear stress and platelet-derived transforming growth factor-β1 release and activation in animal models of aortic valve stenosis.
Wang W; Vootukuri S; Meyer A; Ahamed J; Coller BS
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1924-32. PubMed ID: 24903096
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.
Yu Z; Seya K; Daitoku K; Motomura S; Fukuda I; Furukawa K
J Pharmacol Exp Ther; 2011 Apr; 337(1):16-23. PubMed ID: 21205918
[TBL] [Abstract][Full Text] [Related]
12. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology.
Davies MJ; Treasure T; Parker DJ
Heart; 1996 Feb; 75(2):174-8. PubMed ID: 8673757
[TBL] [Abstract][Full Text] [Related]
13. Expression of smooth muscle cell markers and co-activators in calcified aortic valves.
Latif N; Sarathchandra P; Chester AH; Yacoub MH
Eur Heart J; 2015 Jun; 36(21):1335-45. PubMed ID: 24419809
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase in bicuspid aortic valve disease.
Aicher D; Urbich C; Zeiher A; Dimmeler S; Schäfers HJ
Ann Thorac Surg; 2007 Apr; 83(4):1290-4. PubMed ID: 17383329
[TBL] [Abstract][Full Text] [Related]
15. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
16. Increased mesenchymal podoplanin expression is associated with calcification in aortic valves.
Näpänkangas J; Ohtonen P; Ohukainen P; Weisell J; Väisänen T; Peltonen T; Taskinen P; Rysä J
Cardiovasc Pathol; 2019; 39():30-37. PubMed ID: 30616084
[TBL] [Abstract][Full Text] [Related]
17. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis.
Jian B; Narula N; Li QY; Mohler ER; Levy RJ
Ann Thorac Surg; 2003 Feb; 75(2):457-65; discussion 465-6. PubMed ID: 12607654
[TBL] [Abstract][Full Text] [Related]
18. Unicommissural aortic valves: gross, histological, and immunohistochemical analysis of 52 cases (1978-2008).
Fealey ME; Edwards WD; Miller DV; Maleszewski JJ
Cardiovasc Pathol; 2012; 21(4):324-33. PubMed ID: 22206734
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-κB-hypoxia-inducible factor-2 pathway in aortic valve stenosis.
Akahori H; Tsujino T; Naito Y; Sawada H; Sugahara M; Fukui M; Ohyanagi M; Mitsuno M; Miyamoto Y; Masuyama T
J Heart Valve Dis; 2014 Sep; 23(5):558-66. PubMed ID: 25799704
[TBL] [Abstract][Full Text] [Related]
20. Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.
Lee S; Levy RJ; Christian AJ; Hazen SL; Frick NE; Lai EK; Grau JB; Bavaria JE; Ferrari G
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
